Tilley W - Search Results

1

Androgen receptor coregulators and their involvement in the development and progression of prostate cancer.

Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM. Chmelar R, et al. Among authors: tilley w. Int J Cancer. 2007 Feb 15;120(4):719-33. doi: 10.1002/ijc.22365. Int J Cancer. 2007. PMID: 17163421 Free article. Review.

2

Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells.

Hall RE, Tilley WD, McPhaul MJ, Sutherland RL. Hall RE, et al. Among authors: tilley wd. Int J Cancer. 1992 Nov 11;52(5):778-84. doi: 10.1002/ijc.2910520518. Int J Cancer. 1992. PMID: 1428232

3

Prostate cancer in a transgenic mouse.

Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Greenberg NM, et al. Among authors: tilley wd. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3439-43. doi: 10.1073/pnas.92.8.3439. Proc Natl Acad Sci U S A. 1995. PMID: 7724580 Free PMC article.

4

Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

Tilley WD, Buchanan G, Hickey TE, Bentel JM. Tilley WD, et al. Clin Cancer Res. 1996 Feb;2(2):277-85. Clin Cancer Res. 1996. PMID: 9816170

5

Role of the androgen receptor in human breast cancer.

Birrell SN, Hall RE, Tilley WD. Birrell SN, et al. Among authors: tilley wd. J Mammary Gland Biol Neoplasia. 1998 Jan;3(1):95-103. doi: 10.1023/a:1018730519839. J Mammary Gland Biol Neoplasia. 1998. PMID: 10819508 Review.

6

Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer.

Han G, Foster BA, Mistry S, Buchanan G, Harris JM, Tilley WD, Greenberg NM. Han G, et al. Among authors: tilley wd. J Biol Chem. 2001 Apr 6;276(14):11204-13. doi: 10.1074/jbc.M008207200. Epub 2000 Nov 3. J Biol Chem. 2001. PMID: 11063747 Free article.

7

Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.

Park JJ, Irvine RA, Buchanan G, Koh SS, Park JM, Tilley WD, Stallcup MR, Press MF, Coetzee GA. Park JJ, et al. Among authors: tilley wd. Cancer Res. 2000 Nov 1;60(21):5946-9. Cancer Res. 2000. PMID: 11085509

8

Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function.

Buchanan G, Yang M, Harris JM, Nahm HS, Han G, Moore N, Bentel JM, Matusik RJ, Horsfall DJ, Marshall VR, Greenberg NM, Tilley WD. Buchanan G, et al. Among authors: tilley wd. Mol Endocrinol. 2001 Jan;15(1):46-56. doi: 10.1210/mend.15.1.0581. Mol Endocrinol. 2001. PMID: 11145738

9

Collocation of androgen receptor gene mutations in prostate cancer.

Buchanan G, Greenberg NM, Scher HI, Harris JM, Marshall VR, Tilley WD. Buchanan G, et al. Among authors: tilley wd. Clin Cancer Res. 2001 May;7(5):1273-81. Clin Cancer Res. 2001. PMID: 11350894

10

Contribution of the androgen receptor to prostate cancer predisposition and progression.

Buchanan G, Irvine RA, Coetzee GA, Tilley WD. Buchanan G, et al. Among authors: tilley wd. Cancer Metastasis Rev. 2001;20(3-4):207-23. doi: 10.1023/a:1015531326689. Cancer Metastasis Rev. 2001. PMID: 12085963 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page